Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pharmaceutical Product Development announced it added two new leaders in product development.
read more
Wednesday, January 03, 2018
Pharmaceutical Product Development announced Colin Hill has been named to the company’s board of directors.
read more
Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Jay Dixon as senior vice president, global quality and compliance. Dixon’s expertise will enhance PPD’s ability to deliver industry-leading drug development services and...
read more
Pharmaceutical Product Development, LLC (PPD) today announced the addition of Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team. De Silva will focus on key strategic initiatives vital to ...
read more
Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Henry Levy as executive vice president of client development and commercial services. Levy leads PPD’s customer-facing teams to optimize strategies and deliver results ...
read more
Pharmaceutical Product Development, LLC (PPD) today announced it has acquired Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.
read more
Friday, December 11, 2020
PostEra has announced a strategic partnership with Pfizer with the goal of accelerating small molecule drug discovery by developing a platform technology based on generative chemistry.
read more
greenovation Biotech GmbH and Baylor Research Institute today announced positive preclinical results of greenovation’s plant-made version of human Alpha-Galactosidase (Gal) for use as enzyme-replacement-therapy (ERT) in patients suffering from Fabry ...
read more
Saturday, January 28, 2017
Porton Fine Chemicals, a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, has announced that Porton USA, L.L.C., a wholly-owned subsidiary of Porton, has entered into a stock purchase ...
read more
Codexis and Porton Pharma announce a collaboration to deploy Codexis’ biocatalyst technology within Porton’s global custom intermediate and API development and manufacturing business.
read more
Thursday, January 02, 2025
Porton Pharma Solutions and Dragon Sail Pharmaceutical Co., Ltd. signed a strategic cooperation agreement in Guilin, southern of China. This collaboration aims to carry out in-depth cooperation in the research, development, production, and supply ...
read more
Monday, February 05, 2018
Portage announced its subsidiary, PPL, has formed a new joint venture company to develop more effectively-targeted drugs to treat chronic conditions including cancer.
read more
Friday, December 11, 2015
Porsolt SAS, a preclinical in vivo efficacy and safety CRO, has acquired Fluofarma, a Bordeaux-based company focused on the provision of cell-based assays and in vitro screening services.
read more
Thursday, January 23, 2025
Polyrizon Ltd. has commenced preliminary work related to the Good Manufacturing Practice (GMP) manufacturing process for its PL-14 allergy blocker in preparation for its planned 2025 clinical trial. The company works closely with Eurofins CDMO, ...
read more
Wednesday, March 06, 2024
Polyplus (part of Satorius) company, Xpress Biologics, has received a good manufacturing practice (GMP) certification for recombinant protein production and renewed the January 2023 GMP certification for DNA production at the facility located in ...
read more